Reporting owner

Gaslightwala Abizer

Reporting owner CIK 0002049375 · CEO · Director

View SEC filings ↗

These transactions appear in filings associated with this reporting owner. Jointly reported quantities and amounts are unallocated; they are not this owner's individual purchases or total holdings. Names and roles reflect the relevant filing, and a reporting owner may be a person or an organization.

Reset

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

8 dated transactions · 1 of 1 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Aug 18, 2026Akari Therapeutics PlcStock Option (Right to Buy)Gaslightwala AbizerStock award
Oct 14, 2026Akari Therapeutics PlcAmerican Depositary Shares representing Ordinary SharesGaslightwala AbizerExercise / conversion
Oct 14, 2026Akari Therapeutics PlcAmerican Depositary Shares representing Ordinary SharesGaslightwala AbizerExercise / conversion
Sep 29, 2026Akari Therapeutics PlcAmerican Depositary Shares representing Ordinary SharesGaslightwala AbizerStock award
Dec 16, 2025Akari Therapeutics PlcPre-Funded Warrants to purchase ADRsGaslightwala AbizerPurchase
Dec 16, 2025Akari Therapeutics PlcWarrants to purchase ADRsGaslightwala AbizerPurchase
Dec 16, 2025Akari Therapeutics PlcPre-Funded Warrants to purchase ADRsGaslightwala AbizerPurchase
Dec 16, 2025Akari Therapeutics PlcWarrants to purchase American Depositary Shares ("ADRs")Gaslightwala AbizerPurchase

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Transactions in associated filings

Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedCompanyReporting ownersType / securityQuantityPrice / reference valueDetails
Trade: Akari Therapeutics PlcAKTX · company listings
Gaslightwala AbizerCEO · Director
Stock awardStock Option (Right to Buy)Derivative security · Code A174,0000Value: 0Currency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listings
Gaslightwala AbizerCEO · Director
Exercise / conversionAmerican Depositary Shares representing Ordinary SharesNon-derivative security · Code M7,7330.0004Value: 3.0932Currency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listings
Gaslightwala AbizerCEO · Director
Exercise / conversionAmerican Depositary Shares representing Ordinary SharesNon-derivative security · Code M19,3330.0004Value: 7.7332Currency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listings
Gaslightwala AbizerCEO · Director
Stock awardAmerican Depositary Shares representing Ordinary SharesNon-derivative security · Code A6,4309.72Value: 62,499.6Currency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listings
Gaslightwala AbizerCEO · Director
PurchasePre-Funded Warrants to purchase ADRsDerivative security · Code P773,3230.4041 *Value: 312,499.8243Currency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listings
Gaslightwala AbizerCEO · Director
PurchaseWarrants to purchase ADRsDerivative security · Code P773,323Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listings
Gaslightwala AbizerCEO · Director
PurchasePre-Funded Warrants to purchase ADRsDerivative security · Code P309,3280.4041 *Value: 124,999.4448Currency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listings
Gaslightwala AbizerCEO · Director
PurchaseWarrants to purchase American Depositary Shares ("ADRs")Derivative security · Code P309,328Not reported *Value: Not reportedCurrency not specifiedView ↗